Gene · 5476
Papers2,520
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,520
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pharmacokinetic considerations to optimize clinical outcomes for COVID-19 drugs. | Trends Pharmacol Sci | 2022 | 36374805 | PubTator, text mining | PubMed |
| How Choice of Model Membrane Affects Protein-Glycosphingolipid Interactions: Insights from Native Mass Spectrometry. | Anal Chem | 2022 | 36367338 | PubTator, text mining | PubMed |
| Clinical spectrum and outcome of nine patients with a novel genetic variant of galactosialidosis in the Kingdom of Bahrain. | JIMD Rep | 2022 | 36341164 | PubTator, text mining | PubMed |
| Identification of active natural products that induce lysosomal biogenesis by lysosome-based screening and biological evaluation. | Heliyon | 2022 | 36325146 | PubTator, text mining | PubMed |
| Cognitive aspects of MELAS and CARASAL. | Cereb Circ Cogn Behav | 2022 | 36324419 | PubTator, text mining | PubMed |
| A cell free biomembrane platform for multimodal study of influenza virus hemagglutinin and for evaluation of entry-inhibitors against hemagglutinin. | Front Mol Biosci | 2022 | 36310596 | PubTator, text mining | PubMed |
| Comprehensive molecular characterization of a rare case of Philadelphia chromosome-positive acute myeloid leukemia. | Cold Spring Harb Mol Case Stud | 2022 | 36307214 | PubTator, text mining | PubMed |
| In Silico Structural Analysis of Serine Carboxypeptidase Nf314, a Potential Drug Target in Naegleria fowleri Infections. | Int J Mol Sci | 2022 | 36293059 | PubTator, text mining | PubMed |
| An LC-MS/MS assay for enzymatic characterization of methylthioalkylmalate synthase (MAMS) involved in glucosinolate biosynthesis. | Methods Enzymol | 2022 | 36280361 | PubTator, text mining | PubMed |
| Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia: An Overview of Systematic Reviews. | Int J Clin Pract | 2022 | 36277468 | PubTator, text mining | PubMed |
| A clinical review of HIV integrase strand transfer inhibitors (INSTIs) for the prevention and treatment of HIV-1 infection. | Retrovirology | 2022 | 36273165 | PubTator, text mining | PubMed |
| Considerations into pharmacogenomics of COVID-19 pharmacotherapy: Hope, hype and reality. | Pulm Pharmacol Ther | 2022 | 36265833 | PubTator, text mining | PubMed |
| Novel approach for tracking interdisciplinary research productivity using institutional databases. | J Clin Transl Sci | 2022 | 36259067 | PubTator, text mining | PubMed |
| Tensile strain and altered synovial tissue metabolism in human knee osteoarthritis. | Sci Rep | 2022 | 36253398 | PubTator, text mining | PubMed |
| Sialidase Inhibitors with Different Mechanisms. | J Med Chem | 2022 | 36252951 | PubTator, text mining | PubMed |
| Particle swarm optimization artificial intelligence technique for gene signature discovery in transcriptomic cohorts. | Comput Struct Biotechnol J | 2022 | 36249564 | PubTator, text mining | PubMed |
| Malnutrition leads to increased inflammation and expression of tuberculosis risk signatures in recently exposed household contacts of pulmonary tuberculosis. | Front Immunol | 2022 | 36248906 | PubTator, text mining | PubMed |
| Synergistic action of organophosphates and COVID-19 on inflammation, oxidative stress, and renin-angiotensin system can amplify the risk of cardiovascular maladies. | Toxicol Appl Pharmacol | 2022 | 36240863 | PubTator, text mining | PubMed |
| Current Progress in the Chemoenzymatic Synthesis of Natural Products. | Molecules | 2022 | 36234909 | PubTator, text mining | PubMed |
| The First 5'-Phosphorylated 1,2,3-Triazolyl Nucleoside Analogues with Uracil and Quinazoline-2,4-Dione Moieties: A Synthesis and Antiviral Evaluation. | Molecules | 2022 | 36234748 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5476/papers?page=19